2012
DOI: 10.1007/978-3-642-33555-6
|View full text |Cite
|
Sign up to set email alerts
|

Spatio-temporal Image Analysis for Longitudinal and Time-Series Image Data

Abstract: In the context of Alzheimer's disease (AD), state-of-the-art methods separating normal control (NC) from AD patients or CN from progressive MCI (mild cognitive impairment patients converting to AD) achieve decent classification rates. However, they all perform poorly at separating stable MCI (MCI patients not converting to AD) and progressive MCI. Instead of using features extracted from a single temporal point, we address this problem using descriptors of the hippocampus evolutions between two time points. To… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…A number of MRI studies have detected atrophy in the entorhinal cortex (ERC), hippocampus and amygdala associated with clinical disease severity (Devanand et al, 2007;La Joie et al, 2012;Miller et al, 2015b) and years to AD dementia conversion (Atiya et al, 2003;Kantarci and Jack, 2003). More recent MRI studies have focused on evidence of atrophy that precede clinical symptoms (Jack et al, 2004;Csernansky et al, 2005;den Heijer et al, 2006;Apostolova et al, 2010;Dickerson et al, 2011;Miller et al, 2013;Soldan et al, 2015;Pettigrew et al, 2016), often detecting these smaller changes using time-series data analysis (Durrleman et al, 2012) and survival analysis. These MRI biomarkers of AD-related atrophy prior to manifestation of clinical symptoms are of interest because (1) they may aid in assessing efficacy of therapeutic interventions and (2) they may aid in the identification of populations that can benefit from therapeutic intervention prior to clinical symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…A number of MRI studies have detected atrophy in the entorhinal cortex (ERC), hippocampus and amygdala associated with clinical disease severity (Devanand et al, 2007;La Joie et al, 2012;Miller et al, 2015b) and years to AD dementia conversion (Atiya et al, 2003;Kantarci and Jack, 2003). More recent MRI studies have focused on evidence of atrophy that precede clinical symptoms (Jack et al, 2004;Csernansky et al, 2005;den Heijer et al, 2006;Apostolova et al, 2010;Dickerson et al, 2011;Miller et al, 2013;Soldan et al, 2015;Pettigrew et al, 2016), often detecting these smaller changes using time-series data analysis (Durrleman et al, 2012) and survival analysis. These MRI biomarkers of AD-related atrophy prior to manifestation of clinical symptoms are of interest because (1) they may aid in assessing efficacy of therapeutic interventions and (2) they may aid in the identification of populations that can benefit from therapeutic intervention prior to clinical symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…The 3D atlases for each of the groups (normal, CoA, RAA+ALSA, DAA) were created using the classical MIRTK atlas generation tool [8, 9] (Fig. 2).…”
Section: Methodsmentioning
confidence: 99%